Emergence of Carbapenem-Resistant Escherichia Coli in Taiwan: Resistance Due to Combined CMY-2 Production and Porin Deficiency

REFERENCES

• Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spec-trum 13-1actamases (ESBLs). Clin Microbiol Infect 2000; 6 (9): 460–3.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8 (6): 321–31.
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-13-1actamases: the quiet before the storm? Clin Microbiol Rev 2005; 18 (2): 306–25.
   PubMed Web of Science ®Google Scholar
• Chow JW, Shlaes DM. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J Antimicrob Chemother 1991; 28 (4): 499–504.
   PubMed Web of Science ®Google Scholar
• Raimondi A, Traverso A, Nikaido H. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Pro-teus rettgeri lack porins. Antimicrob Agents Chemother 1991; 35 (6): 1174–80.
   PubMed Web of Science ®Google Scholar
• Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is asso-ciated with the combination of ACT-1, a plasmid-mediated AmpC13-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41 (3): 563–9.
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L, Pascual A, Hernandez-Alles S, Al-varez-Diaz D, Suarez Al, Tran J, et al. Roles of 13-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999; 43 (7): 1669–73.
   PubMed Web of Science ®Google Scholar
• Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coil associated with plasmid-determined CMY-413-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43 (5): 1206–10.
   PubMed Web of Science ®Google Scholar
• Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaAcT413-lactamase produc-tion, porin OmpK35/36 insertional inactivation, and down-reg-ulation of the phosphate transport porin phoE. Antimicrob Agents Chemother 2006; 50 (10): 3396–406.
   PubMed Web of Science ®Google Scholar
• Pavez M, Neves P, Dropa M, Matte MH, Grinbaum RS, Elmor de Araujo MR, et al. Emergence of carbapenem-resistant Escherichia coil producing CMY-2-type AmpC 13-lactamase in Brazil. J Med Microbiol 2008; 57 (Pt 12): 1590-2.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Clinical and Lab-oratory Standards Institute, Wayne, PA, 2006; 16th informa-tional supplement M100-S16.
   Google Scholar
• Bohm H, Karch H. DNA fingerprinting of Escherichia coil 0157:H7 strains by pulsed-field gel electrophoresis. J Clin Mi-crobiol 1992; 30 (8): 2169–72.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233–9.
   PubMed Web of Science ®Google Scholar
• Bonnet R, Sampaio JL, Labia R, De Champs C, Sirot D, Chanal C, et al. A novel CTX-M13-lactamase CTX-M-8 in cefo-taxime-resistant Enterobacteriaceae isolated in Brazil. Antimi-crob Agents Chemother 2000; 44 (7): 1936–42.
   PubMed Web of Science ®Google Scholar
• Mabilat C, Goussard S. PCR detection and identification of genes for extended-spectrum 13-lactamases. In: Persing DH ST, Tenover FC et al., editor. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology; 1993. p. 553-9.
   Google Scholar
• Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum b-lactam resist-ance SHV-8 in a strain of Escherichia coil during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41 (3): 647–53.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Ko WC, Tsai SH, Wu HM, Jin YT, Wu JJ. Dissemination of CTX-M-3 and CMY-213-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 2000; 38 (12): 4320–5.
   PubMed Web of Science ®Google Scholar
• Woodford N, Tierno PM, Jr., Young K, Tysall L, Palepou MF, Ward E, et al. Outbreak of Klebsiella pneumoniae produc-ing a new carbapenem-hydrolyzing class A 13-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 2004; 48 (12): 4793–9.
   PubMed Web of Science ®Google Scholar
• Su LH, Chen HL, Chia JH, Liu SY, Chu C, Wu TL, et al. Distribution of a transposon-like element carrying blacmy_2 among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother 2006; 57 (3): 424–9.
   PubMed Web of Science ®Google Scholar
• Afzal-Shah M, Woodford N, Livermore DM. Characteri-zation of OXA-25, OXA-26, and OXA-27, molecular class D 13-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001; 45 (2): 583–8.
   PubMed Web of Science ®Google Scholar
• Wu TL, Siu LK, Su LH, Lauderdale TL, Lin FM, Leu HS, et al. Outer membrane protein change combined with co-exist-ing TEM-1 and SHV-1 13-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J Antimicrob Chemother 2001; 47 (6): 755–61.
   PubMed Web of Science ®Google Scholar
• Mammeri H, Nordmann P, Berkani A, Eb F. Contribution of extended-spectrum AmpC (ESAC) 13-lactamases to car-bapenem resistance in Escherichia coil. FEMS Microbiol Lett 2008; 282 (2): 238–40.
   PubMed Web of Science ®Google Scholar
• Liu YF, Yan JJ, Ko WC, Tsai SH, Wu JJ. Characterization of carbapenem-non-susceptible Escherichia coil isolates from a university hospital in Taiwan. J Antimicrob Chemother 2008; 61 (5): 1020–3.
   PubMed Web of Science ®Google Scholar
• Lee CH, Chu C, Liu JW, Chen YS, Chiu CJ, Su LH. Col-lateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of biaDl leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae produc-ing CTX-M-3 and SHV-513-lactamases. J Antimicrob Chemother 2007; 60 (2): 410–3.
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemase: the versatile 13-lactamases. Clin Microbiol Rev 2007; 20 (3): 440–58.
   PubMed Web of Science ®Google Scholar
• Urban C, Bradford P, Tuckman M, Segal-Maurer S, We-hbeh W, Grenner L, et al. Carbapenem-resistant Escherichia coil harboring Klebsiella pneumonie carbapenemase 13-lactamases associated with long-term care facilities. Clin Infect Dis 2008; 46 (6): e127–30.
   PubMedGoogle Scholar
• Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Mi-crobiol Infect 2008; 14 (11): 1010–9.
   PubMed Web of Science ®Google Scholar
• Chen TL, Wu RC, Shaio MF, Fung CP, Cho WL. Acqui-sition of a plasmid-bome b1a058 gene with an upstream 151008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother 2008; 52 (7): 2573–80.
   PubMed Web of Science ®Google Scholar
• Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF. An OXA-66/0XA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acineto-bacter baumannii. Antimicrob Agents Chemother 2007; 51 (11): 3844–52.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo-13-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001;45 (8): 2224–8.
   PubMed Web of Science ®Google Scholar
• Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-13-lactamase genes in Taiwan. Diagn Microbiol Infect Dis 2007; 59 (2): 211–6.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Ko WC, Wu JJ. Identification of a plasmid en-coding SHV-12, TEM-1, and a variant of IMP-2 metallo-13-lacta-mase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45 (8): 2368–71.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Ko WC, Tsai SH, Wu HM, Wu JJ. Outbreak of in-fection with multidrug-resistant Klebsiella pneumoniae carrying b1a8 in a university medical center in Taiwan. J Clin Microbiol 2001; 39 (12): 4433–9.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Ko WC, Chuang CL, Wu JJ. Metallo-13-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J Antimicrob Chemother 2002; 50 (4): 503–11.
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L. Extended-spectrum 13-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14 Suppl 1: 82–9.
   Google Scholar
• Davin-Regli A, Botta JM, James CE, Lavigne JP, Cheva-lier J, Garnotel E, et al. Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr Drug Targets 2008; 9 (9): 750–9.
   PubMed Web of Science ®Google Scholar
• Bishop RE. Structural biology of membrane-intrinsic beta-barrel enzymes: sentinels of the bacterial outer membrane. Biochim Biophys Acta 2008; 1778 (9): 1881–96.
   PubMed Web of Science ®Google Scholar
• Kaltman O, Motakefi A, Wretlind B, Kahn M, Olsson-Lil-jequist B, Giske CG. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels. J Antimicrob Chemother 2008; 62 (5): 986–90.
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L, Hemandez-Alles S, Alberti S, Tomas JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother 1996; 40 (2): 342–8.
   PubMed Web of Science ®Google Scholar
• Hernandez-Alles S, Alberti S, Alvarez D, Domenech-Sanchez A, Martinez-Martinez L, Gil J, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology1999; 145 (Pt 3): 673–9.
   PubMed Web of Science ®Google Scholar